We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Trial on the Efficacy and Safety of Virgin Coconut Oil Compared to Mineral Oil in the Treatment of Uremic Xerosis

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01445431
First Posted: October 3, 2011
Last Update Posted: October 3, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Jacqueline Michelle G. de las Alas, M.D., University of the Philippines
  Purpose
Among adult patients with chronic kidney disease undergoing hemodialysis, what is the efficacy and safety of virgin coconut oil compared to mineral oil as a therapeutic moisturizer for uremic xerosis?

Condition Intervention Phase
Uremic Xerosis Other: Virgin Coconut Oil Other: Mineral Oil Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: A Randomized Controlled Trial on the Efficacy and Safety of Virgin Coconut Oil Compared to Mineral Oil in the Treatment of Uremic Xerosis

Resource links provided by NLM:


Further study details as provided by Jacqueline Michelle G. de las Alas, M.D., University of the Philippines:

Primary Outcome Measures:
  • Change in baseline overall dry skin score [ Time Frame: 4 weeks ]
  • Change in baseline corneometer readings [ Time Frame: 4 weeks ]
    Measurement of skin hydration

  • Change in baseline sebumeter readings [ Time Frame: 4 weeks ]
    Measurement of skin lipids


Secondary Outcome Measures:
  • Change in Quality of life scores [ Time Frame: 4 weeks ]
  • Patient-assessed efficacy [ Time Frame: 4 weeks ]
  • Adverse events [ Time Frame: 4 weeks ]

Enrollment: 45
Study Start Date: April 2011
Study Completion Date: August 2011
Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Virgin Coconut Oil Other: Virgin Coconut Oil
Virgin coconut oil applied to the test site twice daily for four weeks
Active Comparator: Mineral Oil Other: Mineral Oil
Mineral oil applied to the test site twice daily for four weeks

Detailed Description:
Objectives of the Study: The general objective of this study is to assess the efficacy and safety of virgin coconut oil (VCO) compared to mineral oil as a therapeutic moisturizer for uremic xerosis. The specific objectives are as follows: 1) to determine and compare changes in the over-all dry skin score within and between treatment groups at baseline, 2 weeks-post and 4-weeks post application; 2) to quantitatively measure the following skin parameters at baseline, 2-weeks and 4-weeks post application (skin hydration using a corneometer, skin lipids using a sebumeter); 3) to determine and compare changes in quality of life scores within and between treatment groups at baseline, and 4-weeks post application; and 4) to identify the adverse effects of virgin coconut oil and mineral oil when used as moisturizer for uremic xerosis
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   19 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults undergoing maintenance hemodialysis who have mild to severe uremic xerosis

Exclusion Criteria:

  • Patients with known hypersensitivity to the tests oils were excluded from the study as well as patients with open wounds, erosions, and ulcers on the test site and paraplegics and patients with altered sensation on the test sites.
  • Patients with xerosis associated with other dermatologic conditions antedating renal failure were excluded from the study.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01445431


Sponsors and Collaborators
University of the Philippines
Investigators
Principal Investigator: Jacqueline Michelle G de las Alas, MD University of the Philippines
  More Information

Responsible Party: Jacqueline Michelle G. de las Alas, M.D., Medical Officer III, University of the Philippines
ClinicalTrials.gov Identifier: NCT01445431     History of Changes
Other Study ID Numbers: MED 2011-01-03-005
First Submitted: September 26, 2011
First Posted: October 3, 2011
Last Update Posted: October 3, 2011
Last Verified: September 2011

Additional relevant MeSH terms:
Mineral Oil
Emollients
Dermatologic Agents